Has Timothy Walline, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,355 in general payments to Timothy Walline, MD across 95 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Timothy Walline, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Timothy Walline, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Timothy Walline, MD

Ophthalmology · Leawood, KSNPI 1114925294

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,720 of the $5,355 with a category attached, or 88.1%. Alcon accounts for 79.5% of it on its own, with 16 other manufacturers making up the rest.

$5,355in general payments, 2019–2025

Across 95 payments — averaging $56.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alcon$4K
Bausch & Lomb Americas Inc.$410
Mallinckrodt Hospital Products Inc.$199
Harrow Eye, LLC$79
Alimera Sciences, Inc.$59
Glaukos Corporation$54
plus $298 from 11 others

$63,375in research payments, 2019–2025

Across 42 payments — averaging $1508.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Alcon Research LLC$63K

What the payments were for

Travel & lodging$62712%
Food & beverage$4,72088%
Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alcon	60	$4,256
Bausch & Lomb Americas Inc.	7	$410
Mallinckrodt Hospital Products Inc.	5	$199
Harrow Eye, LLC	3	$79
Alimera Sciences, Inc.	3	$59
Glaukos Corporation	2	$54
ANI Pharmaceuticals, Inc.	2	$47
Kala Pharmaceuticals, Inc.	2	$45
Carl Zeiss Meditec USA, Inc.	2	$40
Regeneron Healthcare Solutions, Inc.	1	$33
Novartis	2	$30
Genentech USA, Inc.	1	$26
Amgen	1	$19
Rxsight Inc	1	$15
Coopervision Inc.	1	$15
Sun Pharmaceutical Industries Inc.	1	$14
Rayner Intraocular Lenses Limited	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,355 in reported general payments places this provider in the 85th percentile of 135 ophthalmology providers in Kansas.

See all ophthalmology providers in Kansas →

Medicare billing

Part B allowed, 2024

$334,447

Medicare patients

1,682

Services billed

2,390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RestasisCyclosporine	14	$20,537
Cyclosporine	28	$13,371
Prednisolone Acetate	454	$12,816
Ofloxacin	347	$3,567
Latanoprost	65	$1,400
Acyclovir	38	$464
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	37	$441
ErythromycinErythromycin Base	29	$345
Timolol Maleate	18	$222
Doxycycline Hyclate	14	$168
ValacyclovirValacyclovir Hcl	11	$75

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Leawood

John DoaneLeawood$496K
Matthew SniegowskiLeawood$22K
Alaina GerenLeawood$4K
Kevin PikeyLeawood$3K
Alexander VuLeawood$2K
Daniel DurrieOverland Park$974K
John HunkelerOverland Park$218K
Christopher PoleOverland Park$129K
Blake CooperLenexa$100K
Miranda BisharaPrairie Village$45K

See the full list for Kansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →